Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Børre Fevang

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Expert Review of Clinical Immunology|March 30, 2023
Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectivesBørre Fevang
Frontiers in Immunology|May 14, 2023
Cellular immunity in COVID-19 and other infections in Common variable immunodeficiencyRagnhild Øye Løken, Børre Fevang
Journal of Clinical Immunology|November 23, 2018
Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic ModificationsSilje F Jørgensen, Børre Fevang, Pål Aukrust
Malaria Research and Treatment|December 12, 2018
Malaria and Malnutrition: Kwashiorkor Associated with Low Levels of ParasitaemiaPer Fevang, Kirsten Havemann, Børre Fevang, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2025
Necrotising soft tissue infection in the head and neck region, 2017-2023Nadja Tanovic, Ellen Kvestad, Trine Kåsine, et al.
BMC Research Notes|August 14, 2019
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosisTrygve Holmøy, Børre Fevang, David Benee Olsen, et al.
AIDS (London, England)|December 4, 2008
Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapyJan K Damås, Linn Landrø, Børre Fevang, et al.
Rheumatology (Oxford, England)|July 10, 2007
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammationVigdis Bjerkeli, Jan Kristian Damås, Børre Fevang, et al.
Clinical Immunology (Orlando, Fla.)|February 24, 2009
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiencyBørre Fevang, Jesper Eugen-Olsen, Arne Yndestad, et al.
Clinical Immunology (Orlando, Fla.)|December 7, 2016
Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiencyEli Taraldsrud, Pål Aukrust, Silje Jørgensen, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Expert Review of Clinical Immunology|March 30, 2023
Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectivesBørre Fevang
Frontiers in Immunology|May 14, 2023
Cellular immunity in COVID-19 and other infections in Common variable immunodeficiencyRagnhild Øye Løken, Børre Fevang
Journal of Clinical Immunology|November 23, 2018
Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic ModificationsSilje F Jørgensen, Børre Fevang, Pål Aukrust
Malaria Research and Treatment|December 12, 2018
Malaria and Malnutrition: Kwashiorkor Associated with Low Levels of ParasitaemiaPer Fevang, Kirsten Havemann, Børre Fevang, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2025
Necrotising soft tissue infection in the head and neck region, 2017-2023Nadja Tanovic, Ellen Kvestad, Trine Kåsine, et al.
BMC Research Notes|August 14, 2019
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosisTrygve Holmøy, Børre Fevang, David Benee Olsen, et al.
AIDS (London, England)|December 4, 2008
Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapyJan K Damås, Linn Landrø, Børre Fevang, et al.
Rheumatology (Oxford, England)|July 10, 2007
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammationVigdis Bjerkeli, Jan Kristian Damås, Børre Fevang, et al.
Clinical Immunology (Orlando, Fla.)|February 24, 2009
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiencyBørre Fevang, Jesper Eugen-Olsen, Arne Yndestad, et al.
Clinical Immunology (Orlando, Fla.)|December 7, 2016
Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiencyEli Taraldsrud, Pål Aukrust, Silje Jørgensen, et al.
Pageof 7